Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010

27 Apr 2012

Abstract excerpt

The World Health Organization (WHO) has developed a global laboratory network to support human immunodeficiency virus drug resistance genotyping for public health surveillance in resource-limited countries. Blinded proficiency panels are an essential part of a genotyping quality-assurance program and are used to monitor the reliability of genotyping data in the WHO laboratory network. Laboratories in Europe,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22544186
DOI: 10.1093/cid/cir992

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010PMID 22544186Read ↗

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Semantic proximity Read ↗

HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency ProgrammeSemantic proximity Read ↗

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.Semantic proximity Read ↗

External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand.Semantic proximity Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.Semantic proximity Read ↗

Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.Semantic proximity Read ↗

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.Semantic proximity Read ↗

TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesSemantic proximity Read ↗

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.Semantic proximity Read ↗

Next Generation Sequencing Based In-house HIV Genotyping Method: Validation ReportSemantic proximity Read ↗

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.